Contract research CDMO stocks
Heavily traded in Contract research CDMO
Turnover over $10M/day18 of about 60 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| 207940.KSSamsung Biologics Co.,Ltd. | $68.00B | −10.92% | Oct 27, 2026 |
| IQVIQVIA Holdings Inc. | $327.50M | +40.76% | Nov 3, 2026 |
| 4901.TFUJIFILM Holdings Corporation | $13.71B | −9.97% | Nov 5, 2026 |
| MEDPMedpace Holdings, Inc. | $151.26M | +19.94% | Oct 19, 2026 |
| CRLCharles River Laboratories International, Inc. | $252.02M | +79.39% | Nov 4, 2026 |
| ICLRICON Public Limited Company | $107.65M | −0.90% | Oct 21, 2026 |
| HALOHalozyme Therapeutics, Inc. | $185.31M | +41.41% | Nov 2, 2026 |
| SHCSotera Health Company | $44.91M | +14.11% | Nov 3, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
55 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 207940.KS | Samsung Biologics Co.,Ltd. | $48.84B | Large cap | −10.92% |
| IQV | IQVIA Holdings Inc. | $43.73B | Large cap | +40.76% |
| 4901.T | FUJIFILM Holdings Corporation | $25.11B | Large cap | −9.97% |
| MEDP | Medpace Holdings, Inc. | $16.62B | Large cap | +19.94% |
| CRL | Charles River Laboratories International, Inc. | $13.04B | Large cap | +79.39% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −0.90% |
| HALO | Halozyme Therapeutics, Inc. | $12.25B | Large cap | +41.41% |
| 0ILL.L | Laboratorios Farmaceuticos Rovi, S.A. | $5.97B | Mid cap | −4.27% |
| STVN | Stevanato Group S.p.A. | $5.82B | Mid cap | −18.72% |
| SHC | Sotera Health Company | $5.29B | Mid cap | +14.11% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.17B | Mid cap | −25.45% |
| FTRE | Fortrea Holdings Inc. | $1.66B | Small cap | +70.69% |
| GXI.DE | Gerresheimer AG | $1.10B | Small cap | −34.65% |
| ACRS | Aclaris Therapeutics, Inc. | $830.20M | Small cap | +206.52% |
| OXB.L | Oxford Biomedica plc | $718.73M | Small cap | −23.40% |
| EVO | Evotec SE | $597.05M | Small cap | −52.00% |
| EVT.DE | Evotec SE | $586.78M | Small cap | −51.74% |
| KE | Kimball Electronics, Inc. | $575.97M | Small cap | −16.34% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | $353.81M | Small cap | −22.12% |
| 005250.KS | GC Corp. | $323.37M | Small cap | −37.70% |
| 2475.T | WDB Holdings Co., Ltd. | $217.11M | Small cap | +1.11% |
| 008490.KS | Suheung Co., Ltd. | $172.31M | Small cap | −24.41% |
| CDXS | Codexis, Inc. | $162.07M | Small cap | −39.34% |
| LFCR | Lifecore Biomedical, Inc. | $160.88M | Small cap | −44.66% |
| SLV.WA | Selvita S.A. | $135.48M | Small cap | −18.15% |
| 8095.T | Astena Holdings Co., Ltd. | $134.21M | Small cap | +2.06% |
| ALECR.PA | Eurofins-Cerep SA | $105.99M | Small cap | 0.00% |
| EAPI.PA | Euroapi S.A. | $94.01M | Micro cap | −71.12% |
| 2927.T | AFC-HD AMS Life Science Co., Ltd. | $80.70M | Micro cap | +0.86% |
| CSBR | Champions Oncology, Inc. | $68.48M | Micro cap | −40.72% |
| 6568.T | KNC Laboratories Co., Ltd. | $61.96M | Micro cap | +12.58% |
| HVO.L | hVIVO plc | $59.46M | Micro cap | −29.95% |
| CTE.AX | Cryosite Limited | $41.08M | Micro cap | +37.21% |
| 7079.T | WDB coco Co., Ltd. | $39.43M | Micro cap | −4.26% |
| MAB.WA | Mabion S.A. | $34.39M | Micro cap | −15.69% |
| NSYS | Nortech Systems Incorporated | $31.91M | Micro cap | +16.46% |
| 2183.T | Linical Co., Ltd. | $29.62M | Micro cap | −38.81% |
| 2342.T | Transgenic Group Inc. | $27.33M | Micro cap | +16.51% |
| IXI.L | IXICO plc | $22.16M | Micro cap | −34.78% |
| ALTAO.PA | Aton | $18.95M | Micro cap | +84.21% |
| FAB.L | Fusion Antibodies plc | $15.62M | Micro cap | −16.07% |
| IDT.AX | IDT Australia Limited | $14.44M | Micro cap | −27.69% |
| NAII | Natural Alternatives International, Inc. | $12.30M | Micro cap | −39.32% |
| 6190.T | PhoenixBio Co., Ltd. | $8.05M | Micro cap | −27.66% |
| GELS | Gelteq Limited | $7.28M | Micro cap | −52.11% |
| EPN.AX | Epsilon Healthcare Limited | $6.94M | Micro cap | +4.17% |
| PRM.L | Proteome Sciences plc | $6.63M | Micro cap | −59.54% |
| PYC.L | Physiomics Plc | $3.21M | Micro cap | +7.84% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.65M | Micro cap | +49.69% |
| 0RB1.L | Laboratorio Reig Jofre, S.A. | — | — | −7.02% |
| BANB.SW | Bachem Holding AG | — | — | +23.13% |
| DESN.SW | Dottikon ES Holding AG | — | — | −13.38% |
| LONN.SW | Lonza Group AG | — | — | −2.19% |
| PPGN.SW | PolyPeptide Group AG | — | — | +73.43% |
| SFZN.SW | Siegfried Holding AG | — | — | −17.33% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 55 companies grouped under the Contract research CDMO theme. The median market value in the group is $135.48M. Across the group, the median move over the past trading day is 0.00%. 44% of the 55 with a 200-day average trade above it. Price change over the past year runs from −43.1% to +46.4% across the middle 80 percent of the group, with a median of −10.9%.